BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia
Authors
Keywords
-
Journal
OncoImmunology
Volume 5, Issue 10, Pages e1146843
Publisher
Informa UK Limited
Online
2016-04-26
DOI
10.1080/2162402x.2016.1146843
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sensor Function for Butyrophilin 3A1 in Prenyl Pyrophosphate Stimulation of Human Vγ2Vδ2 T Cells
- (2015) Hong Wang et al. JOURNAL OF IMMUNOLOGY
- Activation of Human γδ T Cells by Cytosolic Interactions of BTN3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin
- (2015) David A. Rhodes et al. JOURNAL OF IMMUNOLOGY
- Vγ9Vδ2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6
- (2014) Felipe Riaño et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells
- (2014) Andrew Sandstrom et al. IMMUNITY
- A Comprehensive Analysis of Primary Acute Myeloid Leukemia Identifies Biomarkers Predicting Susceptibility to Human Allogeneic Vγ9Vδ2 T Cells
- (2014) Stefan Gundermann et al. JOURNAL OF IMMUNOTHERAPY
- Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
- (2014) Martin Wilhelm et al. Journal of Translational Medicine
- Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid
- (2013) Atif S. M. Idrees et al. CANCER SCIENCE
- Butyrophilin 3A1 Plays an Essential Role in Prenyl Pyrophosphate Stimulation of Human V 2V 2 T Cells
- (2013) H. Wang et al. JOURNAL OF IMMUNOLOGY
- At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies
- (2013) Franco Locatelli et al. JOURNAL OF LEUKOCYTE BIOLOGY
- At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias
- (2013) Håkan Norell et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Dysfunctional V 9V 2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells
- (2012) M. Coscia et al. BLOOD
- Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human T-cell subset
- (2012) C. Harly et al. BLOOD
- The Molecular Basis for Modulation of Human Vγ9Vδ2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies
- (2012) Aparna Palakodeti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human V 9V 2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts
- (2012) J. Gertner-Dardenne et al. JOURNAL OF IMMUNOLOGY
- Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy
- (2012) Volker Kunzmann et al. JOURNAL OF IMMUNOTHERAPY
- BTN3A2 Expression in Epithelial Ovarian Cancer Is Associated with Higher Tumor Infiltrating T Cells and a Better Prognosis
- (2012) Cécile Le Page et al. PLoS One
- High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote V 9V 2 T-Cell Chemotaxis and Cytotoxicity In Vivo
- (2011) I. Benzaid et al. CANCER RESEARCH
- Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside
- (2011) Barbara Castella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Differential role for CD277 as a co-regulator of the immune signal in T and NK cells
- (2011) Nassima Messal et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Reduced Expression of the Mevalonate Pathway Enzyme Farnesyl Pyrophosphate Synthase Unveils Recognition of Tumor Cells by V 9V 2 T Cells
- (2009) J. Li et al. JOURNAL OF IMMUNOLOGY
- A robust xenotransplantation model for acute myeloid leukemia
- (2009) P V Sanchez et al. LEUKEMIA
- High antitumor activity of RLI, an interleukin-15 (IL-15)-IL-15 receptor fusion protein, in metastatic melanoma and colorectal cancer
- (2009) A. Bessard et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now